Kansas health officials say that the state will resume using the Johnson and Johnson single-dose COVID-19 vaccine after federal agencies determined its benefits outweigh a rare risk of blood clots.
Administration of the J and J shot was paused on April 13th by the Centers for Disease Control and Prevention and the Food and Drug Administration following reports that some recipients developed a rare disorder involving blood clots within two weeks of vaccination.
Federal health officials decided that J and J’s one-and-done vaccine is critical to fight the pandemic.
It decided that the small clot risk could be handled with warnings to help younger women decide if they should use that shot or an alternative.
The CDC noted there had been 15 reported cases of the blood clots out of nearly eight million J and J inoculations.
The state expects to receive 1,700 doses of the J&J vaccine the week of May 3.